Approach to persistent ascites after liver transplantation

Persistent ascites (PA) after liver transplantation (LT), commonly defined as ascites lasting more than 4 wk after LT, can be expected in up to 7% of patients. Despite being relatively rare, it is associated with worse clinical outcomes, including higher 1-year mortality. The cause of PA can be divi...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of hepatology Vol. 14; no. 9; pp. 1739 - 1746
Main Authors Ostojic, Ana, Petrovic, Igor, Silovski, Hrvoje, Kosuta, Iva, Sremac, Maja, Mrzljak, Anna
Format Journal Article
LanguageEnglish
Published Baishideng Publishing Group Inc 27.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Persistent ascites (PA) after liver transplantation (LT), commonly defined as ascites lasting more than 4 wk after LT, can be expected in up to 7% of patients. Despite being relatively rare, it is associated with worse clinical outcomes, including higher 1-year mortality. The cause of PA can be divided into vascular, hepatic, or extrahepatic. Vascular causes of PA include hepatic outflow and inflow obstructions, which are usually successfully treated. Regarding modifiable hepatic causes, recurrent hepatitis C and acute cellular rejection are the leading ones. Considering predictors for PA, the presence of ascites, refractory ascites, hepato-renal syndrome type 1, spontaneous bacterial peritonitis, hepatic encephalopathy, and prolonged ischemic time significantly influence the development of PA after LT. The initial approach to patients with PA should be to diagnose the treatable cause of PA. The stepwise approach in evaluating PA includes diagnostic paracentesis, ultrasound with Doppler, and an echocardiogram when a cardiac cause is suspected. Finally, a percutaneous or transjugular liver biopsy should be performed in cases where the diagnosis is unclear. PA of unknown cause should be treated with diuretics and paracentesis, while transjugular intrahepatic portosystemic shunt and splenic artery embolization are treatment methods in patients with refractory ascites after LT.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Corresponding author: Anna Mrzljak, FEBG, PhD, Associate Professor, Department of Gastroenterology and Hepatology, University Hospital Center Zagreb, Kišpatićeva ulica 12, Zagreb 10000, Croatia. anna.mrzljak@gmail.com
Supported by the Croatian Science Foundation, Emerging and Neglected Hepatotropic Viruses after Solid Organ and Hematopoietic Stem Cell Transplantation (to Mrzljak A), No. IP-2020-02-7407.
Author contributions: Ostojic A contributed to the literature review, analysis, and interpretation of the data, drafting of the initial manuscript, and final approval of the manuscript; Petrovic I, Silovski H, Kosuta I, and Sremac M contributed to the analysis and interpretation of the data, and final approval of the manuscript; Mrzljak A contributed to the conception and design of the manuscript, critical revised the initial manuscript, and approved the final manuscript.
ISSN:1948-5182
1948-5182
DOI:10.4254/wjh.v14.i9.1739